Skip to main content
Livermore
Livermore
ZHEN

Two Sigma Advisers, LP

SEC CIK
0001478735
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of NVO by Two Sigma Advisers, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−119,600−100.0%Sold outHolders
Q3 2025119,600$6.64M<0.1%−1,272,100−91.4%ReducedHolders
Q2 20251,391,700$96.1M0.2%−3,465,100−71.3%ReducedHolders
Q1 20254,856,800$337.3M0.8%+3,835,100+375.4%AddedHolders
Q4 20241,021,700$87.9M0.2%+885,300+649.0%AddedHolders
Q3 2024136,400$16.2M<0.1%−22,500−14.2%ReducedHolders
Q2 2024158,900$22.7M0.1%+18,700+13.3%AddedHolders
Q1 2024140,200$18.0M<0.1%+2,400+1.7%AddedHolders
Q4 2023137,800$14.3M<0.1%+14,100+11.4%AddedHolders
Q3 2023123,700$11.2M<0.1%−44,700−26.5%ReducedConverted for a 2-for-1 splitHolders
Q2 202384,200$13.6M<0.1%+72,000+590.2%AddedHolders
Q1 202312,200$1.94M<0.1%−3,300−21.3%ReducedHolders
Q4 202215,500$2.10M<0.1%−14,000−47.5%ReducedHolders
Q3 202229,500$2.94M<0.1%−271,900−90.2%ReducedHolders
Q2 2022301,400$33.6M0.1%−84,600−21.9%ReducedHolders
Q1 2022386,000$42.9M0.1%−290,600−43.0%ReducedHolders
Q4 2021676,600$75.8M0.2%−39,300−5.5%ReducedHolders
Q3 2021715,900$68.7M0.2%+555,300+345.8%AddedHolders
Q2 2021160,600$13.5M<0.1%+59,500+58.9%AddedHolders
Q1 2021101,100$6.82M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.